Founded in 1994, the company has production and R&D bases in Yantai, Nanjing, Beijing and Luzhou, with more than 3,000 employees. At present, more than 50 products have been listed, covering anti-tumor, cardiovascular, endocrine, orthopedics, digestion, central nervous system and other fields. Among them, the sales of innovative drugs and new preparations with independent intellectual property rights account for more than 90%, covering 30 provinces and cities across the country. The products have entered more than 4,000 hospitals and exported to many countries and regions.
Lvye Pharmaceutical, as an innovative enterprise, invests 10% of its sales revenue in new drug research and development every year, and the R&D investment ratio ranks in the forefront of domestic pharmaceutical enterprises. The group has more than 300 professional R&D personnel, established an R&D system that meets international standards, and has the "State Key Laboratory of Long-acting Targeted Preparations" approved by the Ministry of Science and Technology, which has reached the international advanced level in the research fields of microsphere technology.